Pasqualone Frank
- SEC CIK
- 0001597334
No open-market purchases or sales filed in the past year.
Current role at each company
- ENVB Enveric Biosciences, Inc.Directoras of Jun 3, 2026
- TBPH Theravance Biopharma, Inc.SVP, CHIEF BUSINESS OFFICERas of Nov 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pasqualone Frank as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ENVB Enveric Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Pasqualone FrankDirector | PPurchase | +1.00K | $2.14 | +$2.14K | New position1.00K after |